miRecule

BiotechnologySeedGaithersburg, USmirecule.com

Latest round

Seed

Last raised

May 2021

Total raised

$5.7M

Investors

6

About miRecule

miRecule, Inc.Founded in 2016 and headquartered in Gaithersburg, US, miRecule, Inc. specializes in RNA therapeutics. The company was co-founded by Anthony Saleh and Ashwin Kulkarni, with Saleh serving as the CEO.miRecule™ is dedicated to developing RNA-based therapeutics aimed at cancer and muscular dystrophy by leveraging its proprietary DREAmiR™ platform. Their focus is on individualizing treatment using genomic and outcome data, particularly targeting facioscapulohumeral muscular dystrophy (FSHD) through collaboration with Sanofi to create an innovative antibody-RNA conjugate.miRecule generates revenue through strategic collaborations that involve upfront and milestone payments based on development progress. The company is exploring opportunities for expansion into additional therapeutic areas, leveraging its proprietary technologies, and aims to broaden its market presence in North America and Europe.

Who invested in miRecule

6 investors across 1 round

See all investors in miRecule

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Seed

    May 27, 2021

    Amount

    $5.7M

    Investors

    Locked

Questions about miRecule

Who invested in miRecule?

miRecule has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has miRecule raised?

miRecule has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did miRecule last raise money?

miRecule's most recent round on record is a Seed, in May 2021.

What does miRecule do?

miRecule is a biotechnology company.

Where is miRecule headquartered?

miRecule is headquartered in Gaithersburg, US.

Which VCs invest in companies like miRecule?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at miRecule's stage. Their profiles are linked below.

Raising like miRecule? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.